Increased metabolic risk in adolescents patients treated with atypical antipsychotic drugs: Preliminary results

被引：0
|
作者：
Cuerda Compes, C. [1 ]
Arango, C. [1 ]
Velasco, C. [1 ]
De Castro, M. [1 ]
Paron, L. [1 ]
Breton, I. [1 ]
Camblor, M. [1 ]
Garcia-Peris, P. [1 ]
机构：
[1] HGU Gregorio Maranon, Nutr Unit, Madrid, Spain
来源：
SCHIZOPHRENIA BULLETIN | 2007年 / 33卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：497 / 497
页数：1
相关论文
共 50 条
  • [1] Metabolic disturbances in patients with paranoid schizophrenia treated with atypical antipsychotic drugs
    Bardenshtein, L. M.
    Mkrtumyan, A. M.
    Aleshkina, G. A.
    DIABETES MELLITUS, 2010, 13 (02): : 42 - 44
  • [2] High prevalence of metabolic risk factors associated with cardiovascular disease in schizophrenic patients treated with atypical antipsychotic drugs
    Larsen, JT
    Fagerquist, M
    Holdrup, M
    Christensen, B
    Sigalin, C
    Nilsson, P
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S512 - S513
  • [3] Atypical antipsychotic drugs and hyperglycemia in adolescents
    Koller, E
    Malozowski, S
    Doraiswamy, PM
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (20): : 2547 - 2548
  • [4] Adjunctive effects of aripiprazole on metabolic profiles: Comparison of patients treated with olanzapine to patients treated with other atypical antipsychotic drugs
    Wang, Liang-Jen
    Ree, Shao-Chun
    Huang, Yu-Shu
    Hsiao, Cheng-Cheng
    Chen, Chih-Ken
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 40 : 260 - 266
  • [5] Metabolic Consequences of Atypical Antipsychotic Drugs
    Harold E. Lebovitz
    Psychiatric Quarterly, 2003, 74 : 277 - 290
  • [6] Metabolic consequences of atypical antipsychotic drugs
    Lebovitz, HE
    PSYCHIATRIC QUARTERLY, 2003, 74 (03) : 277 - 290
  • [7] Metabolic disease in patients taking typical and atypical antipsychotic drugs
    Mackin, P
    Watkinson, H
    Young, AH
    BIPOLAR DISORDERS, 2005, 7 : 73 - 73
  • [8] QTc interval measurement and metabolic parameters in psychiatric patients taking typical or atypical antipsychotic drugs: A preliminary study
    Mackin, P
    Young, AH
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (11) : 1386 - 1391
  • [9] Metabolic testing after the FDA warning on atypical antipsychotic drugs and diabetes risk
    Morrato, Elaine H.
    Newcomer, John W.
    Kamat, Siddhesh
    Baser, Onur
    Harnett, James
    Cuffel, Brian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S204 - S204
  • [10] Risk of adverse health outcome and metabolic syndrome in adolescents treated with antipsychotics: preliminary results
    Merchan-Naranjo, J.
    Giraldez-Quiroga, M.
    Moreno, C.
    Pina, L.
    Parellada, M.
    Tapia, C.
    Rodriguez, P.
    Arango, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S496 - S497
12345